These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Lipid disorders in NIDDM: implications for treatment. Taskinen MR; Smith U J Intern Med; 1998 Nov; 244(5):361-70. PubMed ID: 9845851 [TBL] [Abstract][Full Text] [Related]
17. Management of hyperlipidaemia. Why, when and how to treat. Oliver MF; Pyörälä K; Shepherd J Eur Heart J; 1997 Mar; 18(3):371-5. PubMed ID: 9076374 [No Abstract] [Full Text] [Related]
18. Metabolic syndrome: cardiovascular risk assessment and management. Wong ND Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567 [TBL] [Abstract][Full Text] [Related]
19. Dyslipidaemia and cardiovascular risk in diabetes. Cullen P; von Eckardstein A; Souris S; Schulte H; Assmann G Diabetes Obes Metab; 1999 Jul; 1(4):189-98. PubMed ID: 11228753 [No Abstract] [Full Text] [Related]
20. Predicting CHD risk in patients with diabetes. Chowdhury T; Lasker SS Diabet Med; 2002 Jan; 19(1):83-4. PubMed ID: 11869313 [No Abstract] [Full Text] [Related] [Next] [New Search]